NCT04300140 2023-10-30Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaAravive, Inc.Phase 1/2 Terminated72 enrolled
NCT03729245 2023-04-11A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)Nektar TherapeuticsPhase 3 Terminated623 enrolled 14 charts